Fig. 1
From: Designing circulating tumor DNA-based interventional clinical trials in oncology
The application of ctDNA in clinical trials across different disease settings in oncology. IO, Immuno-oncology therapy; MRD, Minimal residual disease
Fig. 1 | Genome Medicine